Anantha J, Goulding SR, Tuboly E, O’Mahony AG, Moloney GM, Lomansey G, McCarthy CM, Collins LM, Sullivan AM, O’Keeffe GW (2022) NME1 protects against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell models of Parkinson’s Disease. Mol Neurobiol 59(1). https://doi.org/10.1007/s12035-021-02569-6

Baiguera C, Alghisi M, Pinna A, Bellucci A, De Luca MA, Frau L, Morelli M, Ingrassia R, Benarese M, Porrini V, Pellitteri M, Bertini G, Fabene PF, Sigala S, Spillantini MG, Liou HC, Spano PF, Pizzi M (2012) Late-onset parkinsonism in NFκB/c-Rel-deficient mice. Brain 135(9). https://doi.org/10.1093/brain/aws193

Baltus THL, Morelli NR, de Farias CC, Trugilo KP, Okuyama NCM, de Oliveira KB, de Melo LB, Smaili SM, Barbosa DS (2021) Association of -94 ATTG insertion/deletion NFkB1 and c.*126G > A NFkBIA genetic polymorphisms with oxidative and nitrosative stress biomarkers in Brazilian subjects with Parkinson’s Disease. Neuroscience Letters, 740. https://doi.org/10.1016/j.neulet.2020.135487

Bellucci A, Bubacco L, Longhena F, Parrella E, Faustini G, Porrini V, Bono F, Missale C, Pizzi M (2020) Nuclear Factor-κB dysregulation and α-Synuclein Pathology: critical interplay in the pathogenesis of Parkinson’s Disease. Front Aging Neurosci 12. https://doi.org/10.3389/fnagi.2020.00068

Camblor DG, Miranda D, Albaiceta GM, Amado-Rodríguez L, Cuesta-Llavona E, Vázquez-Coto D, Gómez de Oña J, García-Lago C, Gómez J, Coto E (2022) Genetic variants in the NF-κBsignaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients. Hum Immunol 83:8–9. https://doi.org/10.1016/j.humimm.2022.06.002

Article  CAS  Google Scholar 

Camerucci E, Stang CD, Hajeb M, Turcano P, Mullan AF, Martin P, Ross OA, Bower JH, Mielke MM, Savica R (2021) Early-Onset Parkinsonism and Early-Onset Parkinson’s Disease: A Population-Based Study (2010–2015). In Journal of Parkinson’s Disease (Vol. 11, Issue 3). https://doi.org/10.3233/JPD-202464

Coto E, Díaz-Corte C, Tranche S, Gómez J, Alonso B, Iglesias S, Reguero JR, López-Larrea C, Coto-Segura P (2018) Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and their association with type 2 diabetes and impaired renal function. Hum Immunol 79(6):494–498 Epub 2018 Mar 27.PMID: 29601852

Article  CAS  PubMed  Google Scholar 

Coto E, Reguero JR, Avanzas P, Pascual I, Martín M, Hevia S, Morís C, Díaz-Molina B, Lambert JL, Alonso B, Cuesta-LLavona E, Díaz-Corte C, Gómez J (2019) Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and risk for early-onset coronary artery disease. ImmunologyLetters 208. https://doi.org/10.1016/j.imlet.2019.02.007

Coto-Segura P, Gonzalez-Lara L, Gómez J, Eiris N, Batalla A, Gómez C, Requena S, Queiro R, Alonso B, Iglesias S, Coto E (2017) NFKBIZ in Psoriasis: assessing the association with gene polymorphisms and report of a new transcript variant. Hum Immunol 78:5–6. https://doi.org/10.1016/j.humimm.2017.02.008

Article  CAS  Google Scholar 

de López R, Lang V, Zubiarrain A, Sousa A, Vázquez N, Gorostidi A, Águila J, de López A, Rodríguez M, Sánchez-Pernaute R (2016) Mutations in LRRK2 impair NF-ΚB pathway in iPSC-derived neurons. J Neuroinflamm 13(1). https://doi.org/10.1186/s12974-016-0761-x

Dolatshahi M, RanjbarHameghavandi MH, Sabahi M, Rostamkhani S (2021) Nuclear factor-kappa B (NF-κB) in pathophysiology of Parkinson disease: diverse patterns and mechanisms contributing to neurodegeneration. Eur J Neurosci (Vol 54(1). https://doi.org/10.1111/ejn.15242

Feng Y, Chen Z, Xu Y, Han Y, Jia X, Wang Z, Zhang N, Lv W (2023) The central inflammatory regulator IκBζ: induction, regulation and physiological functions. In Frontiers in Immunology (Vol. 14). https://doi.org/10.3389/fimmu.2023.1188253

Flood PM, Qian L, Peterson LJ, Zhang F, Shi JS, Gao HM, Hong JS (2011) Transcriptional factor NF-κb as a target for therapy in Parkinson’s disease. In Parkinson’s Disease. https://doi.org/10.4061/2011/216298

Gao J, Pfeifer D, He LJ, Qiao F, Zhang Z, Arbman G, Wang ZL, Jia CR, Carstensen J, Sun XF (2007) Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese populations. Scand J Gastroenterol 42(3). https://doi.org/10.1080/00365520600880856

Gao M, Wang CH, Sima X, Han XM (2012) NFKB1-94 insertion/deletion ATTG polymorphism contributes to risk of systemic lupus erythematosus. DNA Cell Biol 31(4). https://doi.org/10.1089/dna.2011.1389

Gaunt TR, Rodríguez S, Day IN (2007) Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool ‘CubeX’. BMC Bioinformatics 8:428. https://doi.org/10.1186/1471-2105-8-428

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, Ghosh S, Mosley RL, Gendelman HE, Pahan K (2007) Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson’s disease. Proc Natl Acad Sci USA 104(47). https://doi.org/10.1073/pnas.0704908104

Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y, Hirsch EC (1997) Nuclear translocation of NF-κb is increased in dopaminergic neurons of patients with Parkinson disease. Proc Natl Acad Sci USA 94(14). https://doi.org/10.1073/pnas.94.14.7531

Ju Hwang C, Choi D-Y, Park MH, Hong JT (2017) NF-κB as a key mediator of brain inflammation in Alzheimer’s Disease. CNS Neurol Disorders - Drug Targets 18(1). https://doi.org/10.2174/1871527316666170807130011

Kaltschmidt B, Kaltschmidt C (2015) NF-KappaB in long-term memory and structural plasticity in the adult mammalian brain. In Frontiers in Molecular Neuroscience (Vol. 8, Issue November). https://doi.org/10.3389/fnmol.2015.00069

Kaltschmidt B, Helweg LP, Greiner JFW, Kaltschmidt C (2022) NF-κB in neurodegenerative diseases: Recent evidence from human genetics. In Frontiers in Molecular Neuroscience (Vol. 15). https://doi.org/10.3389/fnmol.2022.954541

Lawrence T (2009) The nuclear factor NF-kappaB pathway in inflammation. In Cold Spring Harbor perspectives in biology (Vol. 1, Issue 6). https://doi.org/10.1101/cshperspect.a001651

Lin CW, Hsieh YS, Hsin CH, Su CW, Lin CH, Wei LH, Yang SF, Chien MH (2012) Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer. PLoS ONE 7(4). https://doi.org/10.1371/journal.pone.0035078

Liu T, Zhang L, Joo D, Sun SC (2017) NF-κBsignaling in inflammation. In Signal Transduction and Targeted Therapy (Vol. 2). https://doi.org/10.1038/sigtrans.2017.23

López-Mejías R, García-Bermúdez M, González-Juanatey C, Castañeda S, Miranda-Filloy JA, Gómez-Vaquero C, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, Blanco R, González-Álvaro I, Llorca J, Martín J, González-Gay MA (2012) NFKB1-94ATTG ins/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis 224(2). https://doi.org/10.1016/j.atherosclerosis.2012.06.008

Mata IF, Ross OA, Kachergus J, Huerta C, Ribacoba R, Moris G, Blazquez M, Guisasola LM, Salvador C, Martinez C, Farrer M, Alvarez V (2006) LRRK2 mutations are a common cause of Parkinson’s disease in Spain. Eur J Neurol 13(4). https://doi.org/10.1111/j.1468-1331.2006.01256.x

Mattson MP, &Meffert MK (2006) Roles for NF-κB in nerve cell survival, plasticity, and disease. In Cell Death and Differentiation (Vol. 13, Issue 5). https://doi.org/10.1038/sj.cdd.4401837Park

MohdSuzairi MSi, Tan SC, Ahmad Aizat AA, MohdAminudin M, SitiNurfatimah MS, Andee ZD, Ankathil R (2013) The functional – 94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer. Cancer Epidemiol 37(5). https://doi.org/10.1016/j.canep.2013.05.007

Park MH, Hong JT (2016) Roles of NF-κB in cancer and inflammatory diseases and their therapeutic approaches. In Cells (Vol. 5, Issue 2). https://doi.org/10.3390/cells5020015

Parrella E, Bellucci A, Porrini V, Benarese M, Lanzillotta A, Faustini G, Longhena F, Abate G, Uberti D, Pizzi M (2019) NF-κB/c-Rel deficiency causes Parkinson’s disease-like prodromal symptoms and progressive pathology in mice. Translational Neurodegeneration 8(1). https://doi.org/10.1186/s40035-019-0154-z

Russo I (2019) The role of LRRK2 on PKA-NFκB pathway in microglia cells: implications for Parkinson’s disease. In Neural Regeneration Research (Vol. 14, Issue 10). https://doi.org/10.4103/1673-5374.257523

Ryan SK, Zelic M, Han Y, Teeple E, Chen L, Sadeghi M, Shankara S, Guo L, Li C, Pontarelli F, Jensen EH, Comer AL, Kumar D, Zhang M, Gans J, Zhang B, Proto JD, Saleh J, Dodge JC, Savova V, Rajpal D, Ofengeim D (2023) Hammond TR.Microgliaferroptosis is regulated by SEC24B and contributes to neurodegeneration.NatNeurosci. 26(1):12–26. https://doi.org/10.1038/s41593-022-01221-3. Epub 2022 Dec 19.PMID: 36536241

Saldaña M, Mullol J, Aguilar E, Bonastre M, Marin C (2007) Nuclear factor kappa-B p50 and p65 subunits expression in dementia with Lewy bodies. Neuropathol Appl Neurobiol 33(3). https://doi.org/10.1111/j.1365-2990.2007.00806.x

Singh S, Singh TG (2020) Role of nuclear factor Kappa B (NF-κB) signalling in neurodegenerative diseases: an mechanistic Approach. Curr Neuropharmacol 18(10). https://doi.org/10.2174/1570159x18666200207120949

Song S, Chen D, Lu J, Liao J, Luo Y, Yang Z et al (2011) NFκB1 and NFκBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population. PLoS ONE 6:e21726

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Taetzsch T, Benusa S, Levesque S, Mumaw CL, Block ML (2019) Loss of NF-κB p50 function synergistically augments microglial priming in the middle-aged brain. J Neuroinflamm 16(1). https://doi.org/10.1186/s12974-019-1446-z

Tranchevent LC, Halder R, Glaab E (2023) Systems level analysis of sex-dependent gene expression changes in Parkinson’s disease. Npj Parkinson’s Disease 9(1). https://doi.org/10.1038/s41531-023-00446-8

Vogel U, Jensen MK, Due KM, Rimm EB, Wallin H, Nielsen MRS, Pedersen APT, Tjønneland A, Overvad K (2011) The NFKB1 ATTG ins/del polymorphism and risk of coronary heart disease in three independent populations. Atherosclerosis 219(1). https://doi.org/10.1016/j.atherosclerosis.2011.06.018

Wang Y, Shan B, Liang Y, Wei H, Yuan J (2018) Parkin regulates NF-κB by mediating site-specific ubiquitination of RIPK1. Cell Death Dis 9(7). https://doi.org/10.1038/s41419-018-0770-z

Zhu B, Park JM, Coffey S, Hsu IU et al Single-cell transcriptomic and proteomic analysis of Parkinson’s disease brains. bioRxiv (2022) 2022-02. https://doi.org/10.1101/2022.02.14.480397